Solvay SA Logo

Solvay SA

SVYSF

(2.0)
Stock Price

34,35 USD

32.5% ROA

49.91% ROE

2.16x PER

Market Cap.

3.923.250.127,09 USD

159.62% DER

10.7% Yield

26.02% NPM

Solvay SA Stock Analysis

Solvay SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Solvay SA Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (26%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

ROE in an average range (12%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (9.07%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (1.04x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-2.107) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Solvay SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Solvay SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Hold

Solvay SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Solvay SA Revenue
Year Revenue Growth
2002 7.919.000.000
2003 7.557.000.000 -4.79%
2004 7.271.000.000 -3.93%
2005 8.562.000.000 15.08%
2006 9.399.000.000 8.91%
2007 9.572.000.000 1.81%
2008 9.490.000.000 -0.86%
2009 8.485.000.000 -11.84%
2010 5.959.000.000 -42.39%
2011 7.563.000.000 21.21%
2012 10.910.000.000 30.68%
2013 10.149.000.000 -7.5%
2014 10.629.000.000 4.52%
2015 10.083.000.000 -5.42%
2016 10.045.000.000 -0.38%
2017 10.984.000.000 8.55%
2018 11.299.000.000 2.79%
2019 11.227.000.000 -0.64%
2020 9.714.000.000 -15.58%
2021 11.435.000.000 15.05%
2022 16.071.000.000 28.85%
2023 12.132.000.000 -32.47%
2023 6.024.000.000 -101.39%
2024 5.332.000.000 -12.98%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Solvay SA Research and Development Expenses
Year Research and Development Expenses Growth
2002 399.000.000
2003 404.000.000 1.24%
2004 408.000.000 0.98%
2005 472.000.000 13.56%
2006 563.000.000 16.16%
2007 556.000.000 -1.26%
2008 564.000.000 1.42%
2009 555.000.000 -1.62%
2010 125.000.000 -344%
2011 154.000.000 18.83%
2012 247.000.000 37.65%
2013 238.000.000 -3.78%
2014 247.000.000 3.64%
2015 232.000.000 -6.47%
2016 234.000.000 0.85%
2017 235.000.000 0.43%
2018 238.000.000 1.26%
2019 323.000.000 26.32%
2020 300.000.000 -7.67%
2021 325.000.000 7.69%
2022 357.000.000 8.96%
2023 356.000.000 -0.28%
2023 35.000.000 -917.14%
2024 32.000.000 -9.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Solvay SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 1.412.000.000
2003 1.359.000.000 -3.9%
2004 1.252.000.000 -8.55%
2005 1.417.000.000 11.64%
2006 1.559.000.000 9.11%
2007 1.523.000.000 -2.36%
2008 1.567.000.000 2.81%
2009 1.482.000.000 -5.74%
2010 482.000.000 -207.47%
2011 641.000.000 24.8%
2012 1.076.000.000 40.43%
2013 1.189.000.000 9.5%
2014 1.225.000.000 2.94%
2015 1.296.000.000 5.48%
2016 1.363.000.000 4.92%
2017 1.037.000.000 -31.44%
2018 1.006.000.000 -3.08%
2019 950.000.000 -5.89%
2020 900.000.000 -5.56%
2021 946.000.000 4.86%
2022 1.088.000.000 13.05%
2023 864.000.000 -25.93%
2023 426.000.000 -102.82%
2024 312.000.000 -36.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Solvay SA EBITDA
Year EBITDA Growth
2002 1.221.000.000
2003 1.091.000.000 -11.92%
2004 1.123.000.000 2.85%
2005 1.019.000.000 -10.21%
2006 1.443.000.000 29.38%
2007 1.781.000.000 18.98%
2008 1.035.000.000 -72.08%
2009 1.379.000.000 24.95%
2010 1.138.000.000 -21.18%
2011 1.063.000.000 -7.06%
2012 1.914.000.000 44.46%
2013 1.716.000.000 -11.54%
2014 2.389.000.000 28.17%
2015 1.647.000.000 -45.05%
2016 1.901.000.000 13.36%
2017 2.107.000.000 9.78%
2018 2.083.000.000 -1.15%
2019 2.332.000.000 10.68%
2020 1.928.000.000 -20.95%
2021 2.289.000.000 15.77%
2022 3.267.000.000 29.94%
2023 2.512.000.000 -30.06%
2023 1.127.000.000 -122.89%
2024 1.184.000.000 4.81%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Solvay SA Gross Profit
Year Gross Profit Growth
2002 2.679.000.000
2003 2.456.000.000 -9.08%
2004 2.494.000.000 1.52%
2005 2.838.000.000 12.12%
2006 3.273.000.000 13.29%
2007 3.330.000.000 1.71%
2008 3.109.000.000 -7.11%
2009 2.990.000.000 -3.98%
2010 1.126.000.000 -165.54%
2011 1.359.000.000 17.14%
2012 2.364.000.000 42.51%
2013 2.305.000.000 -2.56%
2014 2.559.000.000 9.93%
2015 2.332.000.000 -9.73%
2016 2.467.000.000 5.47%
2017 2.719.000.000 9.27%
2018 2.682.000.000 -1.38%
2019 2.983.000.000 10.09%
2020 2.507.000.000 -18.99%
2021 2.927.000.000 14.35%
2022 4.029.000.000 27.35%
2023 3.604.000.000 -11.79%
2023 1.323.000.000 -172.41%
2024 1.236.000.000 -7.04%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Solvay SA Net Profit
Year Net Profit Growth
2002 464.000.000
2003 396.000.000 -17.17%
2004 489.000.000 19.02%
2005 789.000.000 38.02%
2006 791.000.000 0.25%
2007 781.000.000 -1.28%
2008 405.000.000 -92.84%
2009 516.000.000 21.51%
2010 1.776.000.000 70.95%
2011 247.000.000 -619.03%
2012 563.000.000 56.13%
2013 270.000.000 -108.52%
2014 80.000.000 -237.5%
2015 406.000.000 80.3%
2016 621.000.000 34.62%
2017 1.061.000.000 41.47%
2018 877.000.000 -20.98%
2019 118.000.000 -643.22%
2020 -962.000.000 112.27%
2021 948.000.000 201.48%
2022 1.905.000.000 50.24%
2023 880.000.000 -116.48%
2023 2.093.000.000 57.96%
2024 268.000.000 -680.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Solvay SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 5
2003 4 -25%
2004 6 20%
2005 9 37.5%
2006 9 0%
2007 9 0%
2008 5 -100%
2009 6 20%
2010 21 75%
2011 3 -900%
2012 6 66.67%
2013 3 -100%
2014 1 0%
2015 5 100%
2016 6 33.33%
2017 10 40%
2018 8 -25%
2019 1 -700%
2020 -9 111.11%
2021 9 200%
2022 18 50%
2023 8 -125%
2023 20 60%
2024 3 -900%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Solvay SA Free Cashflow
Year Free Cashflow Growth
2002 848.000.000
2003 376.000.000 -125.53%
2004 539.000.000 30.24%
2005 464.000.000 -16.16%
2006 557.000.000 16.7%
2007 419.000.000 -32.94%
2008 514.000.000 18.48%
2009 728.000.000 29.4%
2010 305.000.000 -138.69%
2011 248.000.000 -22.98%
2012 672.000.000 63.1%
2013 432.000.000 -55.56%
2014 634.000.000 31.86%
2015 97.000.000 -553.61%
2016 591.000.000 83.59%
2017 404.000.000 -46.29%
2018 662.000.000 38.97%
2019 958.000.000 30.9%
2020 707.000.000 -35.5%
2021 863.000.000 18.08%
2022 1.097.000.000 21.33%
2023 810.000.000 -35.43%
2023 338.000.000 -139.64%
2024 109.000.000 -210.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Solvay SA Operating Cashflow
Year Operating Cashflow Growth
2002 848.000.000
2003 870.000.000 2.53%
2004 970.000.000 10.31%
2005 969.000.000 -0.1%
2006 1.138.000.000 14.85%
2007 852.000.000 -33.57%
2008 1.277.000.000 33.28%
2009 1.184.000.000 -7.85%
2010 591.000.000 -100.34%
2011 850.000.000 30.47%
2012 1.457.000.000 41.66%
2013 1.299.000.000 -12.16%
2014 1.621.000.000 19.86%
2015 1.134.000.000 -42.95%
2016 1.572.000.000 27.86%
2017 1.226.000.000 -28.22%
2018 1.495.000.000 17.99%
2019 1.815.000.000 17.63%
2020 1.242.000.000 -46.14%
2021 1.499.000.000 17.14%
2022 2.006.000.000 25.27%
2023 1.874.000.000 -7.04%
2023 625.000.000 -199.84%
2024 142.000.000 -340.14%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Solvay SA Capital Expenditure
Year Capital Expenditure Growth
2002 0
2003 494.000.000 100%
2004 431.000.000 -14.62%
2005 505.000.000 14.65%
2006 581.000.000 13.08%
2007 433.000.000 -34.18%
2008 763.000.000 43.25%
2009 456.000.000 -67.32%
2010 286.000.000 -59.44%
2011 602.000.000 52.49%
2012 785.000.000 23.31%
2013 867.000.000 9.46%
2014 987.000.000 12.16%
2015 1.037.000.000 4.82%
2016 981.000.000 -5.71%
2017 822.000.000 -19.34%
2018 833.000.000 1.32%
2019 857.000.000 2.8%
2020 535.000.000 -60.19%
2021 636.000.000 15.88%
2022 909.000.000 30.03%
2023 1.064.000.000 14.57%
2023 287.000.000 -270.73%
2024 33.000.000 -769.7%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Solvay SA Equity
Year Equity Growth
2002 2.686.000.000
2003 2.641.000.000 -1.7%
2004 2.882.000.000 8.36%
2005 3.774.000.000 23.64%
2006 4.456.000.000 15.31%
2007 4.459.000.000 0.07%
2008 4.745.000.000 6.03%
2009 5.160.000.000 8.04%
2010 6.708.000.000 23.08%
2011 6.648.000.000 -0.9%
2012 6.573.000.000 -1.14%
2013 7.452.000.000 11.8%
2014 6.778.000.000 -9.94%
2015 7.480.000.000 9.39%
2016 7.768.000.000 3.71%
2017 7.564.000.000 -2.7%
2018 8.137.000.000 7.04%
2019 9.624.000.000 15.45%
2020 7.303.000.000 -31.78%
2021 8.851.000.000 17.49%
2022 10.664.000.000 17%
2023 1.305.000.000 -717.16%
2023 10.625.000.000 87.72%
2024 1.421.000.000 -647.71%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Solvay SA Assets
Year Assets Growth
2002 9.464.000.000
2003 9.704.000.000 2.47%
2004 10.037.000.000 3.32%
2005 11.240.000.000 10.7%
2006 11.101.000.000 -1.25%
2007 11.180.000.000 0.71%
2008 12.264.000.000 8.84%
2009 12.546.000.000 2.25%
2010 13.723.000.000 8.58%
2011 19.462.000.000 29.49%
2012 18.330.000.000 -6.18%
2013 18.523.000.000 1.04%
2014 17.894.000.000 -3.52%
2015 25.329.000.000 29.35%
2016 24.145.000.000 -4.9%
2017 21.451.000.000 -12.56%
2018 22.000.000.000 2.5%
2019 21.307.000.000 -3.25%
2020 16.792.000.000 -26.89%
2021 20.049.000.000 16.25%
2022 20.661.000.000 2.96%
2023 7.022.000.000 -194.23%
2023 19.921.000.000 64.75%
2024 6.614.000.000 -201.19%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Solvay SA Liabilities
Year Liabilities Growth
2002 5.900.000.000
2003 6.194.000.000 4.75%
2004 6.245.000.000 0.82%
2005 7.320.000.000 14.69%
2006 6.645.000.000 -10.16%
2007 6.721.000.000 1.13%
2008 7.519.000.000 10.61%
2009 7.386.000.000 -1.8%
2010 7.015.000.000 -5.29%
2011 12.814.000.000 45.26%
2012 11.757.000.000 -8.99%
2013 11.071.000.000 -6.2%
2014 11.116.000.000 0.4%
2015 17.849.000.000 37.72%
2016 16.377.000.000 -8.99%
2017 13.887.000.000 -17.93%
2018 13.863.000.000 -0.17%
2019 11.683.000.000 -18.66%
2020 9.489.000.000 -23.12%
2021 11.198.000.000 15.26%
2022 9.997.000.000 -12.01%
2023 5.717.000.000 -74.86%
2023 9.296.000.000 38.5%
2024 5.193.000.000 -79.01%

Solvay SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
66.42
Net Income per Share
17.29
Price to Earning Ratio
2.16x
Price To Sales Ratio
0.56x
POCF Ratio
3.86
PFCF Ratio
12.18
Price to Book Ratio
2.9
EV to Sales
0.8
EV Over EBITDA
3.79
EV to Operating CashFlow
5.49
EV to FreeCashFlow
17.42
Earnings Yield
0.46
FreeCashFlow Yield
0.08
Market Cap
3,92 Bil.
Enterprise Value
5,61 Bil.
Graham Number
70.74
Graham NetNet
-32.39

Income Statement Metrics

Net Income per Share
17.29
Income Quality
7.4
ROE
0.5
Return On Assets
0.28
Return On Capital Employed
0.18
Net Income per EBT
4.52
EBT Per Ebit
0.45
Ebit per Revenue
0.13
Effective Tax Rate
0.73

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.25
Operating Profit Margin
0.13
Pretax Profit Margin
0.06
Net Profit Margin
0.26

Dividends

Dividend Yield
0.11
Dividend Yield %
10.7
Payout Ratio
0.15
Dividend Per Share
4.81

Operating Metrics

Operating Cashflow per Share
9.68
Free CashFlow per Share
3.05
Capex to Operating CashFlow
0.68
Capex to Revenue
0.1
Capex to Depreciation
1.18
Return on Invested Capital
0.07
Return on Tangible Assets
0.32
Days Sales Outstanding
63.73
Days Payables Outstanding
52.51
Days of Inventory on Hand
41.09
Receivables Turnover
5.73
Payables Turnover
6.95
Inventory Turnover
8.88
Capex per Share
6.63

Balance Sheet

Cash per Share
5,36
Book Value per Share
13,47
Tangible Book Value per Share
3.95
Shareholders Equity per Share
12.87
Interest Debt per Share
21.7
Debt to Equity
1.6
Debt to Assets
0.33
Net Debt to EBITDA
1.14
Current Ratio
1.37
Tangible Asset Value
0,42 Bil.
Net Current Asset Value
-2,82 Bil.
Invested Capital
4002000000
Working Capital
0,65 Bil.
Intangibles to Total Assets
0.15
Average Receivables
1,23 Bil.
Average Payables
0,77 Bil.
Average Inventory
613000000
Debt to Market Cap
0.55

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Solvay SA Dividends
Year Dividends Growth
2014 4
2015 4 25%
2016 4 0%
2017 3 -100%
2018 5 60%
2019 2 -400%
2020 5 75%
2021 6 20%
2022 5 -25%
2023 5 0%
2024 5 0%

Solvay SA Profile

About Solvay SA

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, specialty phenols, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the flavors and fragrances industries, as well as synthetic intermediates used in pharmaceuticals, agrochemicals, and electronics. This segment also provides friction reducers, gelling agents, emulsion breakers, surfactants, inhibitors, cementing additives, and biocides for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.

CEO
Mr. Philippe Kehren
Employee
9.000
Address
Rue de Ransbeek, 310
Brussels, 1120

Solvay SA Executives & BODs

Solvay SA Executives & BODs
# Name Age
1 Mr. Carlos Silveira
President of Peroxides GBU
70
2 Dr. Mark Van Bijsterveld
Chief People Officer & Member of Executive Committee
70
3 Mr. Vincent Kamel
President of Performance Polyamides
70
4 Ms. An Nuyttens
President of Aroma Performance & Silica Businesses
70
5 Mr. Lanny Duvall
Chief Operating Officer & Member of Executive Committee
70
6 Mr. Philippe Kehren
Chief Executive Officer, Chairman of Executive Committee & Director
70
7 Ms. Lisa Jane Brown
General Counsel, Corporate Secretary & Member of Executive Committee
70
8 Mr. Michael Finelli
Chief Technology Officer
70
9 Mr. Alexandre Blum
Chief Financial and Strategy Officer & Member of Executive Committee
70
10 Mr. J. Michael Radossich
President of Novecare Business
70

Solvay SA Competitors